Vivitra 150

Trastuzumab -150

Composition

Trastuzumab -150

Company

Zydus

Introduction

Vivitra 150mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Uses

Vivitra 150mg Injection is indicated for its use in the following conditions:

How to Consume

Vivitra 150mg Injection shall either be administered before or after surgery.It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Benefits

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Vivitra 150mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Side Effects

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.

Storage

cold chain

Packaging

1 VIAL

FAQs

What is VIVITRA 150 used for?

Vivitra 150mg Injection is indicated for its use in the following conditions:

How should I take VIVITRA 150?

What are the side effects of VIVITRA 150?

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.

How should I store VIVITRA 150?

cold chain

Need more information about this medicine?

MRP: ₹28,744

Offer: ₹6,500

View Product